• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsUnited-Guardian
    Picture of United-Guardian logo

    UG — United-Guardian Share News

    $6.670.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $30.64m
    • Enterprise Value
      $21.05m
    • Revenue
      $10.55m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • UG Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    UG Dividends
    • Brief: United-Guardian reports Q1 earnings per share $0.11

      13/05/2016 14:00
    • Brief: United Guardian receives FDA approval to market new form of Renacidin

      04/01/2016 14:03
    • Brief: United Guardian says receives FDA approval to market new single-dose form of Renacidin

      04/01/2016 14:01
    • Brief: United Guardian Q3 earnings per share $0.26

      09/11/2015 14:00
    • Brief: United Guardian announces increase in mid-year dividend

      15/05/2015 14:00
    • Brief: United Guardian Q1 earnings per share $0.32

      06/05/2015 18:00
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.